 intracerebr hemorrhag cerebr infarct subdur hematoma acut myocardi infarct thrombolyt therapi thrombolysi myocardi infarct studi thrombolysi myocardi infarct phase II pilot clinic trial thrombolysi myocardi infarct phase II pilot clinic trial patient pilot studi random studi mg recombin tissue-typ plasminogen rt-pa activ combin heparin aspirin patient pilot studi random studi mg rt-pa combin heparin aspirin advers neurolog event patient mg rt-pa cerebr infarct intracerebr hemorrhag subdur hematoma patient mg rt-pa cerebr infarct intracerebr hemorrhag subdur hematoma differ advers neurolog event rt-pa regimen due frequenc intracerebr bleed patient mg rt-pa patient recent month histori stroke elig studi patient histori cerebrovascular diseas inelig earli studi small number patient histori neurolog diseas intermitt cerebr ischem attack stroke stricter elig criteria basi incomplet baselin inform increas frequenc intracerebr hemorrhag patient histori mortal week present patient intracerebr hemorrhag intracerebr hemorrhag sever infrequ complic rt-pa therapi acut myocardi infarct combin frequenc intracerebr hemorrhag subdur hematoma cerebr infarct treatment mg rt-pa compar trial thrombolyt agent acut myocardi infarct